Acta Scientific Pharmacology

Short Communication Volume 3 Issue 10

Brief Scenario of Marfan Syndrome

Gowhar Ahmad*

Professor, Department of Ophthalmology, Florence Hospital Multispeciality Center Chanapora, India

*Corresponding Author: Gowhar Ahmad, Professor, Department of Ophthalmology, Florence Hospital Multispeciality Center Chanapora, India.

Received: September 13, 2021; Published: September 23, 2022


Marfan syndrome is a kind of genetic disorder whose prevalence is equal birth in makes and females also no racial prediction common both in whites and blacks is a kind of connective tissue disorder leading to loss of elasticity.

M syndrome affecting bones cartilage tendons skin blood vessels heart valves cns lungs eyes heart valves.

UTS prevalence in USA is 1 in 5000.

M syndrome is a syndrome complex characterized by ocular manifestations.


    Citation: Gowhar Ahmad. “Brief Scenario of Marfan Syndrome".Acta Scientific Pharmacology 3.10 (2022): 28-29.


    Copyright: © 2022 Gowhar Ahmad. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US